This theory-building article (2017) explores the phenomenological, neurophysiological and philosophical significance of drug-induced ego dissolution with classical psychedelics, dissociative anesthetics, and kappa-opioid receptor agonists and highlights their relevance for investigating the neurophysiological mechanisms underlying the representation and the sense of self.
There is converging evidence that high doses of hallucinogenic drugs can produce significant alterations of self-experience, described as the dissolution of the sense of self and the loss of boundaries between self and world. This article discusses the relevance of this phenomenon, known as “drug-induced ego dissolution (DIED)”, for cognitive neuroscience, psychology and philosophy of mind. Data from self-report questionnaires suggest that three neuropharmacological classes of drugs can induce ego dissolution: classical psychedelics, dissociative anesthetics and agonists of the kappa opioid receptor (KOR). While these substances act on different neurotransmitter receptors, they all produce strong subjective effects that can be compared to the symptoms of acute psychosis, including ego dissolution. It has been suggested that neuroimaging of DIED can indirectly shed light on the neural correlates of the self. While this line of inquiry is promising, its results must be interpreted with caution. First, neural correlates of ego dissolution might reveal the necessary neurophysiological conditions for the maintenance of the sense of self, but it is more doubtful that this method can reveal its minimally sufficient conditions. Second, it is necessary to define the relevant notion of self at play in the phenomenon of DIED. This article suggests that DIED consists in the disruption of subpersonal processes underlying the “minimal” or “embodied” self, i.e., the basic experience of being a self rooted in multimodal integration of self-related stimuli. This hypothesis is consistent with Bayesian models of phenomenal selfhood, according to which the subjective structure of conscious experience ultimately results from the optimization of predictions in perception and action. Finally, it is argued that DIED is also of particular interest for philosophy of mind. On the one hand, it challenges theories according to which consciousness always involves self-awareness. On the other hand, it suggests that ordinary conscious experience might involve a minimal kind of self-awareness rooted in multisensory processing, which is what appears to fade away during DIED.
Papers cited by this study that are also in Blossom
Alonso, J. N., Romero, S., Mañanas, M. A. et al. · International Journal of Neuropsychopharmacology (2015)
Anderson, E. W., Rawnsley, K. · European Neurology (1954)
Carhart-Harris, R. L., Erritzoe, D., Williams, T. et al. · PNAS (2012)
Carhart-Harris, R. L., Friston, K. J. · Brain (2010)
Millière frames drug-induced ego dissolution (DIED) as a reproducible alteration of self-experience produced by high doses of several classes of hallucinogenic drugs, characterised by the loss of self-boundaries and a breakdown of the ordinary sense of being a self. The Introduction situates DIED alongside similar phenomena in psychosis, mystical experiences and deep meditation, and argues that studying drug-induced cases in healthy participants offers a tractable way to investigate mechanisms that are otherwise unpredictable and etiologically complex in endogenous conditions. The paper sets out an interdisciplinary programme: first to document the phenomenology of DIED from questionnaires and narrative reports; second to review neurophysiological and neuropharmacological evidence bearing on its neural basis; third to assess what imaging studies of DIED can legitimately tell us about the neural correlates of the self; fourth to examine the hypothesis that DIED disrupts the ‘‘minimal’’ or embodied self; and finally to consider implications for computational models of selfhood and for philosophical debates about phenomenal self-awareness.
This article is a narrative, interdisciplinary review rather than a primary experimental trial. Millière synthesises evidence from experimental pharmacology, psychometric studies, neuroimaging work, computational modelling and first-person narrative reports. The review discusses findings from placebo-controlled drug studies, psychometric analyses of established instruments (for example the APZ/5D-ASC family and the Hallucinogen Rating Scale), neuroimaging studies with psilocybin and LSD, and pharmacological literature on ketamine and kappa opioid receptor agonists. In addition to literature synthesis, Millière reports an original text-analytic contribution: a quantitative analysis of thousands of user trip reports from the Erowid.org database using latent Dirichlet allocation (LDA) topic modelling to extract semantic patterns and estimate the prevalence of ego-dissolution themes across reports. Exact details of corpus size, preprocessing steps, model parameters and validation procedures are not provided in the extracted text. Where other empirical studies are summarised (for instance PCA and factor-analytic work on custom VAS questionnaires, and the validation study of the 8-item Ego Dissolution Inventory (EDI) with 691 respondents), their methods are described only insofar as they bear on construct validity and measurement issues.
Phenomenology: Across early case reports, controlled experiments and large-scale self-report work, Millière finds convergent evidence that several psychoactive substances can produce experiences described as dissolution of the self or ego. Classical psychedelics (LSD, psilocybin, DMT and mescaline) produce characteristic visual effects and reports of unity, disembodiment and loss of self-boundaries. Standardised instruments such as the APZ/5D-ASC identify Oceanic Boundlessness (OBN) and Dread of Ego Dissolution (DED) dimensions that tap positive and negative valence forms of ego dissolution respectively. A pooled meta-analysis cited for psilocybin showed dose-dependent increases across 5D-ASC scales, with 22% of subjects at a higher psilocybin dose (315 µg/kg) scoring above cut-off for strong OBN. Millière emphasises limitations of single-item measures of ego dissolution used in some imaging studies, and highlights the development and validation of the 8-item Ego Dissolution Inventory (EDI): in an online sample of 691 participants exploratory factor analysis supported a single ego-dissolution factor that correlated strongly with mystical-unity items and discriminated from ‘‘ego inflation’’ items; the strongest loadings included items such as "I experienced a disintegration of my 'self' or ego" (r = 0.897) and "I lost all sense of ego" (r = 0.885). An LDA topic model of thousands of Erowid trip reports suggested that about 7% of reports for substances including Psilocybe, LSD, Salvia, DMT, 5-MeO-DMT, ayahuasca and ketamine contain descriptions matching ego-dissolution themes. Neurophysiology and neuropharmacology: Millière groups substances associated with DIED into three pharmacological classes. Classical psychedelics act principally as agonists at serotonin 5-HT2A receptors, are densely expressed in high-level association cortex (including layer V pyramidal cells), and have been associated with desynchronisation of cortical rhythms, decreases in regional cerebral blood flow and BOLD signal in cortical hubs (thalamus, anterior/posterior cingulate cortices, medial PFC) and changes in DMN dynamics. Psilocybin imaging studies linked DIED measures to DMN–MTL decoupling, decreased alpha power in the posterior cingulate cortex (PCC), reduced parahippocampal–neocortical coupling, and higher neural entropy. One small psilocybin study (n = 15) used PCA on a 22-item VAS questionnaire and found the first principal component correlated with items indexing ego dissolution (e.g., ‘‘I lost all sense of ego’’, Spearman r = 0.842); that component was anticorrelated with connection diversity in the anterior parahippocampal cortex and associated with MTL–neocortex disconnection and reductions in interhemispheric connectivity; unexpectedly, salience-network disintegration also correlated with DIED in that dataset. Separate LSD studies reported increased global functional connectivity in high-level association cortices and the thalamus; single-item ego-dissolution ratings correlated with increased connectivity in bilateral temporoparietal junction and insula, and with decreased resting-state connectivity within the DMN and between parahippocampus and retrosplenial cortex; MEG showed decreased delta and alpha power in PCC linked to DIED. One study linked increases in brain entropy under LSD to long-term increases in the personality trait openness, with the strongest predictive power in participants who experienced ego-dissolution. Dissociative anesthetics (ketamine, PCP, MK-801, dextromethorphan) are NMDA antagonists whose subanesthetic effects include depersonalisation-like phenomena. Ketamine studies reported altered PCC activity, increases in mid-PCC, thalamus and temporal cortex BOLD, and focal suppression of orbitofrontal-subgenual cingulate regions predicting dissociative effects; pre-treatment with lamotrigine (which reduces presynaptic glutamate release) attenuated many ketamine effects. Kappa opioid receptor (KOR) agonists such as salvinorin-A produce intense, often somatically dominated dissociative states; qualitative reports and APZ data indicate that a minority of volunteers experience depersonalisation and loss of bodily ownership with salvinorin-A, but imaging data for KOR agonists are sparse. Millière notes phenomenological overlaps across drug classes but also class-specific differences (e.g., geometric visions with psychedelics, disembodiment with ketamine, intense interoceptive/somatic sensations with Salvia). Computational and phenomenological synthesis: Millière reports that recent Bayesian/free-energy and predictive coding accounts can accommodate DIED by positing that psychedelics and related agents under-constrain top-down priors, increase neural entropy and impair the normal top-down/bottom-up balance that sustains multisensory integration of self-related signals. This disruption could impair self-location and peripersonal space representation, producing the felt loss of self/world boundaries characteristic of DIED.
Millière interprets the assembled evidence as supporting the claim that DIED is a genuine, measurable phenomenon produced by multiple pharmacological classes, and that it is especially informative for questions about the ‘‘minimal’’ or embodied self. Neuroimaging correlates of DIED are taken to reveal candidate necessary neurophysiological conditions for maintaining an ordinary sense of self—for example, integrity in PCC oscillations, parahippocampal–neocortical coupling, salience-network function or interhemispheric connectivity—but the author cautions that these correlates do not establish minimally sufficient conditions. In other words, imaging studies can constrain hypotheses about neural prerequisites of self-experience but cannot by themselves demonstrate sufficiency. A central conceptual move in the Discussion is Millière's distinction between narrative and minimal/embodied notions of self. Drawing on phenomenology and contemporary cognitive neuroscience, he argues that DIED appears more plausibly explained as a disruption of subpersonal multisensory and sensorimotor processes that underpin minimal phenomenal selfhood (self-identification, self-location, egocentric perspective and body ownership) than merely as loss of higher-level narrative identity. Neurophysiological findings that link DIED to PCC alterations, TPJ and insula connectivity changes, MTL–neocortical decoupling and multisensory-integration regions lend support to this view. The paper further engages philosophical debate: DIED challenges strong forms of the ‘‘self-awareness principle’’ (the claim that phenomenal consciousness necessarily entails minimal self-awareness). Millière outlines three possible responses: (1) DIED is only a disruption of the narrative/reflective self, leaving subjective character intact; (2) DIED adds an alienating component to experience rather than subtracting a previously present self; or (3) DIED genuinely shows that aspects of minimal self-awareness can be absent from conscious experience. Millière treats the evidence as more consistent with the claim that ordinary experience includes a minimal self-awareness rooted in multisensory processes that can be disrupted in DIED. Limitations acknowledged include the heterogeneity of drug mechanisms, reliance in some studies on single-item measures of ego dissolution, the use of unvalidated custom questionnaires and small imaging sample sizes; imaging work on KOR agonists is notably scarce. Millière calls for more systematic and psychometrically robust measurement (for example wider use of the EDI), finer-grained first-person descriptions using micro-phenomenological interviews, incorporation of phenomenological methods into neuroimaging (neurophenomenology), and experimental tests of computational hypotheses (for example manipulating sensory input such as sensory deprivation or virtual reality full-body illusions to probe interactions with drug effects).
Hallucinogenic drugs are known to produce profound changes in consciousness. While their immediate effects on perception and mood are well-documented, some of their complex effects at higher doses have received less attention until more recently. In particular, a number of hallucinogenic compounds can induce thorough disturbances of self-consciousness, described as a dramatic breakdown of one's sense of self, a phenomenon commonly referred to as ''ego dissolution''. Similar disturbances of self-consciousness are also reported in several psychiatric disorders, specifically in acute psychosis, as well as mystical-type experiencesand deep meditative states. However, in these endogenous cases, it is difficult to study the mechanisms of ego dissolution, due to its unpredictability and complex etiology. By contrast, the study of Drug-Induced Ego Dissolution (DIED) in healthy individuals offers a way to track down underlying mechanisms of ego dissolution, which in turn could help us gain a better understanding of the neurobiological basis of the sense of self. This article presents an interdisciplinary perspective on DIED and its relevance in studying the sense of self, which is a multifaceted and controversial notion. First, the phenomenology of DIED will be described, based on an analysis of available subjective reports and quantitative data from questionnaires. It will be argued that DIED is a valid construct resulting from the use of psychoactive substances with different chemical structures. Second, this article will review current knowledge about the neurophysiology and neuropharmacology of DIED, which, albeit limited, offers promising insights into its neural underpinning. Third, this article will discuss the relevance of DIED for cognitive neuroscience. In particular, it will address methodological issues within studies investigating neural correlates of DIED, and the extent to which neuroimaging can shed light on the neurobiological basis of the sense of self. In addition, this article will examine the hypothesis that DIED consists in a disruption of the ''embodied'' or ''minimal'' self (the meaning of which will be discussed later) in light of phenomenological evidence, conceptual analysis and recent neurocomputational models of selfhood. Finally, it will be suggested that the study of DIED can also contribute to contemporary philosophical debates on selfawareness.
The profound effects of hallucinogenic compounds on the sense of self have been well known for a long time, especially with regard to psychedelics. Some early experimental studies with mescaline (a psychedelic substance from the peyote cactus Lophophora williamsii) used it to model schizophrenic ''selfdisturbances'', including anomalous body experiences and the feeling of merging with one's surroundingssee, while others concluded that it could replicate the symptoms of depersonalization disorder, characterized by the experience of feeling unreal and detached from one's mental processes and body. Aldous Huxley himself described his personal experimentations with mescaline as leading to a ''final stage of egolessness'', associated with a feeling of unity with everything. In the 1950s and 1960s, a host of experimental studies with the newly synthetized lysergic acid diethylamide (LSD) reached similar conclusions regarding the drug's ability to produce depersonalization-like experiences. Reported effects of LSD in these studies include the blurring or complete disappearance of boundaries between one's body and its environment, feelings of numbness, ''feelings of non-existence'', fear of ''impending dissolution'', feelings of disembodiment and feelings of unity with the universe. Around the same time, similar effects were observed with the administration of psilocybin, the psychoactive component of so-called ''magic mushrooms'' found mainly in the Psilocybe genus. The expression ''ego dissolution'' seems to have emerged in the 50s to describe these effects as observed with LSD and mescaline. Alternative expressions came into use in the late 50s and early 60s, such as ''ego disintegration'', ''ego loss''and ''ego death''. Trying to relate DIED to betterknown conditions, many of the studies published during this period compared the reported effects to the symptoms of depersonalization disorder or to putatively nonpathological mystical states. Several authors also described these effects as ''self-disturbances'' (Ichstörungen), a term introduced by Hans Gruhle (a colleague of Karl Jaspers in Heidelberg) to characterize passivity experiences in schizophreniasee. The notion of ''self-disturbance'' was later systematized by Kurt Schneider, who included it among first-rank symptoms of schizophrenia, as ''alterations of the sense of ''I'', ''me'' or ''mine'''' linked to passivity symptoms; see. Later studies have attempted to capture the subjective effects of hallucinogenic drugs quantitatively by using standardized questionnaires. The use of psychometrics better ensured the validity and consistency of phenomenological reports within and between participants. One of the most widely used self-report questionnaires to measure the effects of psychoactive compounds is Dittrich's Abnormal Mental States (APZ) questionnaireand its revised versions, OAVand 5D-ASC. These questionnaires measure the characteristics of altered states of consciousness along three primary dimensions: Oceanic Boundlessness (OBN), Dread of Ego Dissolution (DED) and Visionary Restructuralization (VR). The first two dimensions are loosely associated with positively and negatively experienced ego dissolution, respectively. The OBN scale includes items measuring positively felt depersonalization, derealization and feelings of unity (e.g., ''It seemed to me that my environment and I were one''), whilst the DED scale measures distressing experiences of depersonalization, thought disorder, and loss of thought and body control (e.g., ''I observed myself as though I were a stranger''). A large number of placebo-controlled studies have reported that healthy participants give on average statistically higher scores to items on the OBN and DED scales after the administration of various psychoactive drugs. Such drugs include: psilocybin, N,N-Dimethyltryptamine (DMT, also found in the shamanic brew ayahuasca;, ketamineand salvinorin-A (found in Salvia divinorum;. A meta-analysis pooling raw data from eight experimental studies, conducted between 1999 and 2008, found that psilocybin significantly increased scores of all 5D-ASC scales in a dose-dependent manner, with higher doses (215 µg/kg and above) being associated with high scores of items in the OBN scale, including those related to ''positively experienced depersonalization''. Although a number of participants did not report significant alterations of self-experience, particularly when receiving lower doses of psilocybin, 22% of participants in the higher dose condition (315 µg/kg) scored above cut-off for experiencing strong OBN. A recent study used a 23-item rating scale questionnaire (based on previous empirical work by) to assess the effects of 2 mg psilocybin. The authors found that after drug administration participants scored highly on the item ''I experienced a disintegration of my self or ego''. Another self-report questionnaire that used the Hallucinogen Rating Scale (HRS) yielded similar results regarding ''subjective alterationsself-awareness'' upon administration of psychoactive substances, such as DMTand salvinorin-A. In addition, several studies have used the Ego Pathology Inventory (EPI), a questionnaire initially designed to measure ''selfdisturbances'' in schizophrenia, to assess the effects of psychoactive compounds on self-consciousness. Vollenweider and colleagues have repeatedly found that ketamine and psilocybin administration significantly increased global EPI scores, including individual scores for the ''ego demarcation'' scale-measuring the blurring of boundaries between self and world-, as well as the ''ego consistency'' scale-measuring the dissolution of the sense of being a single coherent self. One noteworthy limitation of most recent studies directly investigating the phenomenon of ego dissolution, however, is their reliance on a single questionnaire item to measure it, such as ''I experienced a disintegration of my self or ego''. Not only are single-item measurements less reliable than scales with multiple items, by virtue of their limited ability to capture the complex phenomenology of DIED, but they are also more ambiguous, as participants might have widely different understandings of the notions of ''self'' or ''ego''. In addition, items of the 5D-ASC questionnaire itself appear to measure DIED only indirectly, through measuring experiences of unity (''Everything seemed to unify into an oneness'') and disembodiment (''It seemed to me as though I did not have a body anymore''). In a recent double-blind, placebocontrolled study focusing specifically on DIED and its neural correlates, 15 participants completed a custom questionnaire made of 22 Visual Analogue Scale (VAS) items after receiving an injection of 2 mg psilocybin. Rather than using a single-item measurement of DIED, the questionnaire data was reduced using Principal Component Analysis (PCA), a statistical procedure used to identify the principal components of a multidimensional dataset accounting for as much of the variability in the data as possible, under the constraint that variables correlate with each other in each principal component. PCA yielded a first principal component which was mainly associated with VAS items describing ego dissolution, such as ''I lost all sense of ego'' (Spearman's rank correlation coefficient r = 0.842), ''I experienced a loss of separation from my environment'' (r = 0.756) and ''I felt like I was merging with my surroundings'' (r = 0.717). The authors interpreted this convergence as evidence that DIED is a valid construct and corresponds to a meaningful aspect of the subjective experience of participants. Although this result is very promising, it should be noted that the first principal component in this study was also associated with items related to visual abnormalities, such as ''I saw geometric patterns'' (r = 0.725) and ''My imagination was extremely vivid'' (r = 0.841). Furthermore, the authors performed PCA on ratings from their own unvalidated questionnaire. These limitations were recently addressed in a timely article introducing a new 8-item ''Ego Dissolution Inventory'' (EDI) specifically designed to measure DIED. In this study, 691 participants completed an online VAS questionnaire including eight items relating to ego dissolution, and eight items relating to ''ego inflation'' (construed as an ''experience of increased self-assuredness'') for experiences with classical psychedelics, cocaine and alcohol, as well as items selected from the Mystical Experience Questionnaire (MEQ) relating to experiences of unity. The goal was to assess the construct validity of the 8-item EDI, by demonstrating both its discriminant validity against the 8 ego inflation items, and its convergent validity with the MEQ items. The authors used exploratory factor analysis (EFA) to identify latent constructs underlying questionnaire items in a hypothesis-free manner. The analysis supported a model with two main orthogonal factors, respectively accounting for 36.6% and 29.5% of the variance in the sample, and respectively associated with the eight ''ego dissolution'' and the eight ''ego inflation'' items (each item loading strongly onto one of the two factors), thus demonstrating the discriminant validity of the 8-item EDI. Moreover, the score for MEQ-based measure of unitive experience was found to be strongly correlated with the 8-item EDI, demonstrating its convergent validity. This suggests that the proposed EDI is internally valid, has a single-factor psychometric structure and measures a valid construct. The items which loaded the most strongly onto the ''ego dissolution'' factor (r > 0.800) were ''I experienced a disintegration of my ''self'' or ego'' (r = 0.897), ''I lost all sense of ego'' (r = 0.885), ''I experienced a dissolution of my ''self'' or ego'' (r = 0.883), ''All notion of self and identity dissolved away'' (r = 0.845) and ''I felt at one with the universe'' (r = 0.830). In line with previous studies using the ASC questionnaire, the EDI score was found to be strongly associated in a dose-dependent manner with experiences induced by classical psychedelics, as opposed to those induced by cocaine and alcohol. Two potential limitations of the EDI should be noted. First, given that several items are extremely similar, it is not very surprising that they should load onto the same factor. Second, like unvalidated questionnaires, the EDI might be limited by the vagueness of its two key terms, namely ''ego'' and ''self''. Thus, although it measures a valid construct, it does not seem able to shed light on the nature of DIED beyond its standard account as a loss/disintegration/dissolution of the self/ego. Nonetheless, this study represents an important step in the demonstration that DIED is a genuine effect of at least some psychotropic substances, and introduces a reliable way to measure it. An alternative way to get some insight into the phenomenon of DIED is to analyze anecdotal self-reports from drug users, such as those found on the website Erowid.org. Erowid.org is a curated database hosting more than 20,000 ''trip reports'' with various psychoactive substances. A quantitative analysis of randomly selected trip reports regarding Salvia yielded significantly high score for the category ''ego dissolution''it should be noted that the authors used their own measure of ego dissolution with items borrowed from several existing inventories as well as new items). For the present article, a new quantitative analysis of thousands of reports from Erowid.org was performed, using latent Dirichlet allocationto extract semantic patterns from the corpus. The resulting topic model suggested that around 7% of trip reports concerning Psilocybe mushrooms, LSD, Salvia, DMT, 5-MeO-DMT, ayahuasca and ketamine involve the description of an ego dissolution experience. Frequently described aspects of DIED, within this subset of reports, include the loss of self-awareness (''I felt as if ''I'' did no longer exist''), the feeling of dying (''I felt like I was dying''), the loss of boundaries between self and world (''I felt myself mold into the world around me''), the loss of sense of bodily ownership (''I felt disconnected from my body'') and the failure to recognize oneself in a mirror (''I looked at myself in the mirror, only to see a person I could not even recognize''). Thus, the computer-assisted analysis of narrative reports is broadly consistent with questionnaire-driven studies in suggesting that DIED involves a dissolution of self-awareness and a feeling of unity with one's surroundings (or indeed the whole universe). While reports obtained from Erowid.org are somewhat noisy and potentially biased, it should be noted that the unprecedented sample size (thousands of reports), as well as the use of a sophisticated machine learning algorithm extracting topics in a bottom-up (i.e., unsupervised) fashion, increase the significance of the results (see alsoon another use of machine learning with Erowid.org). Therefore, early anecdotal reports, data from validated questionnaires and the above quantitative analysis of narrative reports, all converge to indicate that a range of psychoactive substances, especially above a certain drug-dependent dosage threshold, significantly alter the sense of self in similar ways. However, even if these effects exist, a question lingers about whether or not DIED is a unified phenomenon, rather than a cluster of heterogeneous subjective effects with potentially distinct underlying mechanisms. Two main reasons may warrant such a query: first, the effects associated with DIED are reported with a multiplicity of drugs which have different psychopharmacological profiles; second, the primary dimensions of the APZ questionnaire and its variants (such as 5D-ASC) seem to indicate that the OBN and DED item clusters, both associated with ego dissolution, measure two distinct and potentially incompatible subsets of effects. The first worry will be discussed in the next section of this article. As for the second, it stems from the fact that OBN and DED are respectively designed to measure positive and negative aspects of the experience. This could simply mean that DIED can be experienced in a positive or negative way, the main difference between the two scales lying in the emotional valence of the drug-induced state, not in the type of the subjective experience. Indeed, a number of external factors unrelated to the drug type and dosage, such as personality traits, previous experience, expectations, mood and environment have been shown to strongly predict the pleasant or unpleasant character of the experience. Due to its dramatic intensity, DIED can be a very frightening experience, as evidenced by the large number of individuals reporting a fear of dying. It is not surprising, then, that it is sometimes associated with severe anxiety, which can be greatly alleviated by the willingness to surrender to the experience (e.g., an individual writes in a typical Erowid.org report ''I truly had to let go of myself, and that was profound''). Experienced users seem to have much more positive experiences with DIED on average, as they do not fear for their lives and are not trying to resist the effects of the drug. This could also explain why endogenously occurring ego dissolution, specifically in acute psychotic episodes, generally scores high on the DED dimension of the APZ questionnaire. In other words, when ego dissolution is expected, or at least relatable to drug intake, it is less likely to be associated with anxiety, and more likely to be a blissful experience. This is consistent with the significant positive correlation observed bybetween EDI score and long-term well being and life satisfaction (it should be noted than more than 50% of the participants had used classical psychedelic drugs on more than 10 occasions). Besides, even in endogenous cases, the emotional valence of the experience is also mediated by contextual factors, and accordingly psychotic ego dissolution is sometimes reported as a pleasant experience also. This suggests that it would be wrong to put too much stress on the distinction between OBN and DED, while associating the first dimension with psychedelics and the second with psychotic episodes. A recent psychometric evaluation of the APZ questionnaire, and its revised versions OAV and 5D-ASC, found that the three-dimensional organization of the items was not ideal to measure and compare altered states of consciousness accurately. Instead of the three initial dimensions, a thorough statistical analysis yielded 11 clusters formed from 42 of the 66 original items, two of which seem related to ego dissolution: ''Experience of unity'' (with items such as ''It seemed to me that my environment and I were one'') and ''Disembodiment'' (with items such as ''I seemed to me as though I did not have a body anymore''). In this reorganized model, item clusters related to the affective dimension of the experience, such as ''Spiritual experience'' and ''Anxiety'', were independent. A similar conclusion was reached byafter reducing their custom questionnaire data with PCA. The authors found that ego dissolution, as measured by their first principal component, was ''relatively independent from the emotional valence of the experience'' (p. 12). Indeed, they reported that higher scores with the first principal component did not strongly correlate with the pleasant or anxious character of the experience-which correlated instead with the second principal component of PCA, orthogonal to the first. It should be noted, however, that the first principal component in this study was also loosely associated with two items related to anxiety, ''I felt afraid'' (r = 0.675) and ''I feared loosing control of my mind'' (r = 0.665). Nonetheless, there seems to be convergent evidence to support the idea that DIED can be experienced as a terrifying or blissful state, depending on the context and previous experience of individuals.
The term ''hallucinogen'' does not define a homogenous class of molecules, and is often liberally used to refer to pharmacologically active substances that alter consciousness in dramatic and somewhat unpredictable ways. The subset of hallucinogens that have been shown to induce ego dissolution experiences is not homogenous either, and can be broken down into three main neuropharmacological categories: psychedelics, dissociative anesthetics and kappa opioid receptor (KOR) agonists.
The most prominent neuropharmacological category is the class of ''classical hallucinogens'', also referred to as (classical) ''psychedelics''. Psychedelics share the commonality that they act on the central nervous system (CNS) as agonists of the serotonin 2A (5-HT 2A ) receptor subtype. Although they come from multiple chemical families (tetracyclic ergolines such as LSD, indolealkylamines such as psilocybin and DMT, and phenylalkylamines such as mescaline,, they produce remarkably similar subjective effects, as evidenced by the difficulty of experienced users to discriminate between them in a blind setup. In particular, they produce strong visual effects, such as simple and complex hallucinations, which are less prominent in other classes of psychoactive substances. While phenylalkylamine hallucinogens are selective for 5-HT 2 serotonin receptor subtypes, indolealkylamine hallucinogens bind non-selectively to all 5-HT receptors. There is also converging evidence that 5-HT 2A receptor activation is specifically responsible for mediating the main subjective effects of all psychedelics. Indeed,have shown that the effects of psilocybin are completely blocked by pre-treatment with ketanserin (a 5-HT 2A/2C antagonist) and risperidone (a mixed 5-HT 2A /D 2 antagonist), while pre-treatment with haloperidol (a dopamine D 2 antagonist with weaker affinity for the 5HT 2A receptor) had no effect. Thus, psychedelics can be succinctly defined as serotoninergic hallucinogens, as opposed to other psychoactive substances, which primarily act on different neurotransmitter receptors (such as glutamate and opioid receptors). The neurophysiological effects of serotoninergic hallucinogens are complex. 5-HT 2A receptors are expressed throughout the cortex, and are most densely present in high-level association cortical areas associated with cognitive and perceptual processing. In terms of the laminar structure of the cortex, 5-HT 2A receptors are most densely expressed on excitatory layer V pyramidal neurons, and a recent MEG study suggests that serotoninergic hallucinogens might particularly activate these neurons. Excitation of deep layer V pyramidal neurons is likely to be the cause of the desynchronization of cortical activity recorded by EEG and MEG in multiple studies after the administration of psilocybin, LSD and ayahuasca. Decreases in cerebral blood flow and BOLD signal post-psilocybin were localized in high-association ''hubs'' of the cortex with a high concentration of 5-HT 2A receptors, such as the thalamus, the anterior and posterior cingulate cortices (ACC and PCC) and the medial prefrontal cortex (mPFC;. These regions include key cortical nodes of the default mode network (DMN;, a large-scale intrinsic network which is highly active at rest but less active during goal-directed tasks. It has recently been shown that oral ingestion of ayahuasca (containing DMT) also results in a reduction of DMN activity. The DMN is especially engaged in higher-order, metacognitive operations such as introspection and memory retrieval, and many authors have suggested that the cortical midline structures of the brain, such as the mPFC, the PCC and the ACC, are associated with self-related processing in general (e.g.,. It is worth noting that DMN activity is also reduced during deep meditative states (Brefczynski-, often associated with reports of ego dissolution. Several additional findings by Carhart-Harris et al. () have linked the neurobiological effects of psychedelics to the DMN. While the activation of the DMN is normally negatively correlated with the activation of the task-positive network (TPN), a network of regions that are consistently activated during goal-directed cognition, an increase in DMN-TPN functional connectivity was observed post-psilocybin. A decrease in DMN-TPN inverse coupling has also been observed during meditation, especially with techniques from Vedic and Chinese traditions belonging to the category of ''non-dual awareness'' meditation, which aims at the disappearance of the dichotomy between subject and object. Accordingly, it has been suggested that DMN-TPN orthogonality or ''anti-correlation'' might be necessary to maintain a clear distinction between what is internal/selfrelated and what is external/other-related at the personal level, which would be consistent with the occurrence of ego dissolution after the administration of psychedelics. Functional connectivity analyses also revealed that psilocybin decreases coupling between the PCC and the mPFC, and increases coupling between the mPFC and task-positive areas such as the dorsolateral prefrontal cortex (dlPFC). Given the association of PCC activity with self-related processing, it has been suggested that PCC-mPFC decoupling might play a role in the etiology of DIED. Carhart-Harris and colleagues also observed a highly significant positive correlation between decrease in alpha oscillatory activity in the PCC and ratings of the self-report item ''I experienced a disintegration of my 'self' or 'ego''' post-psilocybin. This indicates that PCC alpha rhythms may play a role in the maintenance of the sense of self. Finally, functional connectivity analyses of the hippocampal region have revealed that psilocybin decreases functional coupling between the nodes of the DMN and the hippocampus and parahippocampal structures of the medial temporal lobes (MTLs;. Electrical stimulation of MTL regions is known to produce dream-like states associated with depersonalization-like experiences. Moreover, neuroimaging has linked depersonalization disorder to the abnormal functioning of these regions. This suggests that DMN-MTL decoupling might play a role in DIED. According to the free-energy principle, the brain is a self-organizing system regulated by the minimization of its free energy. Interpreting the changes in brain connectivity post-psilocybin in light of this principle, Carhart-Harris and colleagues have suggested that serotoninergic hallucinogens produce a ''disorganized'' brain state characterized by a higher neural entropy (a dimensionless quantity measuring disorder) than normal waking consciousness. Accordingly, they hypothesized that the emergence of a coherent sense of self is underpinned by the self-organizing activity of the DMN, associated with a state of lower entropy, and that DMN-MTL decoupling plays an important role in the drug-induced phase transition to a ''primary state'' of consciousness in which DIED is more likely to occur. Given that the parahippocampal cortex (PHC) mediates the connectivity of the hippocampus with major network hubs, including the PCC (part of the DMN) and the dorsomedial prefrontal cortex (dMPFC), they specifically predicted that decoupling of the PHC from the neocortex would correlate with DIED. These hypotheses were tested in a recent study using a custom unvalidated questionnaire (including the item ''I lost all sense of ego'') to investigate the neural correlates of DIED with 15 participants who received 2 mg psilocybin. Two main orthogonal factors were extracted from the item scores using PCA, and the first principal component was hypothesized to be associated to DIED (although it was also associated to items pertaining to perceptual abnormalities). Using the first principal component as a measurement of ego dissolution, the intensity of DIED was found to be strongly anticorrelated to the diversity of connections in the anterior part of the PHC (aPHC), which has specially been linked to dreamy states; since the PHC mediates the connectivity of the hippocampus with the DMN, this result confirms the predicted association between DIED and MTL-DMN decoupling. On the other hand, the diversity of connections in the posteriomedial cortex (including the PCC) did not correlate with DIED, but rather with the negative emotional valence of the experience (hypothetically measured by the second principal component of PCA). Lower diversity of the left frontoparietal regions at baseline was found to indicate a higher likelihood of experiencing DIED. On a larger scale, DIED was found to be associated to the disconnection of MTL regions from the neocortex, as predicted. Surprisingly, the association between DIED and MTL-neocortex decoupling was more generalized than anticipated, since DIED did not correlate with disintegration of the DMN. However, it did correlate with disintegration of the salience network, which was unexpected. The salience network, which enables switching between the default mode and task-related states of brain connectivity, has independently been put forward as a potential candidate in the search for neural correlates of the ''embodied self'', while the DMN might be more closely related to the ''narrative self'' given its role in introspection. Finally, DIED was also found to correlate with reduced interhemispheric connectivity, which was not expected either; this result appears to be consistent with a hypothesis regarding the role of interhemispheric communication in the maintenance of bodily awareness and one's sense of agency. Several recent studies have also investigated the correlates of LSD-induced ego dissolution, using single-item measurements rather than the heterogeneous PCA-driven measurement previously used by. Administration of LSD in healthy participants was found to be associated with an increase in global functional connectivity in high-level association cortices (which partially overlap with the DMN, the salience network and the frontoparietal attention network), as well as in the thalamus. Interestingly, the experience of ego-dissolution and its intensity (as measured by the VAS questionnaire item ''I experienced a disintegration of my 'self' or 'ego''') was found to correlate with this increase in global connectivity, specifically in the bilateral temporoparietal junction (TPJ; angular gyrus) and bilateral insular cortex. Furthermore, the increase in global connectivity in high-level regions particularly involved sensory areas. The TPJ is an important area for multisensory integration and vestibular processing, and its activity has been associated with changes in self-location and in the experienced direction of visuospatial perspective induced by full-body illusions with a head-mounted display. Furthermore, it has been hypothesized that out-of-body experiences (OBE), in which individuals feel located outside of their own physical body (usually at an elevated position) stem from a failure to integrate multisensory information from one's own body at the TPJ. A lesion analysis of OBE-patients also revealed that maximal lesion overlap at the TPJ included the angular gyrus. A recent review suggests that the TPJ might contribute to the maintenance of a sense of self. The insular cortex, in turn, has been associated with processing of interoceptive information, which might also play an important role in the experience of body ownershipand the maintenance of a sense of self. Heautoscopic experiences, in which patients may feel located at several places at the same time, have been linked to lesions of the posterior insular cortex, and might be caused by the disintegration of visuo-somatosensory signals with interoceptive signals. In light of these results it is tempting to speculate, asdo, that increased cross-talk between the angular gyrus, the insula and other brain networks plays a role in the experience of DIED. A separate analysis of the same fMRI data also found that DIED (as measured by the same single VAS item) was correlated with a disintegration of the DMN, i.e., a decrease in resting state functional connectivity within the network, supporting some previous findings with psilocybin-but not the results of the PCA-driven study of DIED. DIED was also found to be strongly correlated with a decrease in resting state functional connectivity between the parahippocampus and retrosplenial cortex. MEG revealed a significant relationship between DIED and decreased delta and alpha power, particularly in the PCC, also in line with previous research on psilocybin. The authors thus suggest that DMN integrity, communication between the parahippocampus and the retrospenial cortex and regular oscillatory rhythms within the PCC may play a role in the maintenance of a sense of self. Finally, another recent study found that the increase in entropic brain activity produced by LSD predicted a long-term increase in the personality trait openness. Moreover, the predictive power of entropy was greatest for participants who had experienced ego-dissolution. To summarize these findings, fMRI data with psilocybin suggested that ego dissolution is linked to MTL-cortical coupling, salience network integrity and interhemispheric connectivity. However, MTL-neocortex decoupling was not emphasized in recent studies on LSD-induced ego dissolution. Rather, these studies linked DIED to increased global cortical connectivity and increased entropy. There is nonetheless a fair share of overlap between the results of studies with psilocybin and LSD, in particular the correlation of DIED with decreased regular oscillatory rhythms in the PCC, and decreased communication between the parahippocampus and the neocortex (e.g., the retrosplenial cortex).
Dissociative anesthetics form the second class of psychoactive substances known to induce ego dissolution experiences. The common characteristic of dissociative anesthetics such as ketamine, phencyclidine (PCP), dizocilpine (MK-801) and dextromethorphan (DXM) at subanesthetic doses is their primary action as antagonists of the N-methyl-Daspartate (NMDA) glutamate receptor. The subanesthetic effects of dissociative anesthetics resemble some of the positive, negative and cognitive symptoms of schizophrenia, and seem to include ego dissolution. These psychotomimetic characteristics have led a lot of researchers to use NMDA receptor antagonists to model the neurobiological mechanisms of psychosis, culminating with glutamatergic models of schizophrenia, according to which it is linked to NMDA receptor hypofunction. Indeed, it is believed that the effects of dissociative anesthetics on consciousness and cognition are mediated by an increase in glutamate release resulting from NMDA receptor blockade, which leads to excessive glutamate activity at non-NMDA receptors. The hypothesis that ketamine acts through increased glutamate release was supported by the finding that pre-treatment with lamotrigine, a drug reported to inhibit presynaptic glutamate release, significantly reduces the psychosis-like effects of ketamine. There is also increasing evidence that glutamatergic dysfunction might be involved in the pathophysiology of depersonalization disorder. For example, two open-label trials used lamotrigine as an add-on medication with antidepressants and found that 50%-70% of depersonalized patients reported improved symptoms. NMDA receptors are widely distributed in the cortex as well as the hippocampus and the amygdala. In rats, ketamine was shown to significantly increase glutamate release in the mPFC. There is also converging evidence that NMDA receptor antagonists, just like serotoninergic hallucinogens, have a significant disruptive effect on PCC activity. An fMRI study on the long-term effects of ketamine in primates found that chronic ketamine administration reduced activity in the ventral tegmental area, the substantia nigra, the PCC and the visual cortex. Ketamine also increased activity in the striatum and entorhinal cortex. Previous studies had found that PCP, MK-801 and ketamine can induce severe metabolic reduction in the PCC. More recently, a study found that during episodic memory retrieval ketamine significantly reduced the activation and the signal changes in the PCC, which correlated positively with psychosis-like symptoms, in accordance with reported alterations of the glutamatergic system in the PCC of schizophrenic patients.performed two experiments using resting-state fMRI to investigate directly the effects of ketamine on regional BOLD signal. In the first experiment, healthy participants received either intravenous ketamine or saline placebo. In the second experiment, participants were pretreated with lamotrigine before ketamine administration. This pre-treatment was done in order to identify the regional effects of ketamine that are mediated by enhanced glutamate release. The results indicated that ketamine administration results in increased activity in the mid-posterior cingulate (mid-PCC), thalamus and temporal cortical regions. At the same time, ketamine decreased activity in ventromedial frontal cortex, including orbitofrontal cortex (OFC) and subgenual cingulate (SC), which strongly predicted dissociative effects. Pre-treatment with lamotrigine prevented these effects and many of the BOLD signal changes. The authors concluded that the increase of glutamate release provoked by NMDA receptor blockade results in aberrant perceptual processing in a network of auditory and visual association cortices (centered on the mid-PCC) and in a focal suppression of the OFC-SC and temporal pole, which would prevent the integration of aberrant percepts with visceromotor function and the sense of self. It is worth noting thatdid not directly measure the experience of ego dissolution, and used instead psychiatric rating scales designed to measure dissociative states. Finally, another recent study found that ketamine decreases resting-state functional connectivity of the DMN to the dorsal nexus (a functional node in the bilateral dMPFC), the pregenual anterior cingulate (PACC) and the mPFC via the PCC. In light of these findings, it is tempting to speculate that aberrant activation of the PCC plays an important role in the occurrence of ego dissolution experiences induced by NDMA receptor antagonists, which would tend to confirm the theory that the neurophysiological basis of DIED is broadly similar across cases involving distinct pharmacological etiologies. While the average item scores on the APZ questionnaire for psilocybin and ketamine reveal that the latter produces stronger feelings of disembodiments, both substances score very high on the OBN subscale of the APZ as well as the ''ego consistency'' subscale of the EPI questionnaire. This broad convergence of the ego dissolving effects of serotoninergic hallucinogens and dissociative anesthetics is confirmed by a recent study with DXM, another NDMA receptor antagonist.
The third class of substances seemingly associated with DIED is constituted by KOR agonists such as salvinorin-A, the psychoactive component of the Mexican plant Salvia divinorum. In addition to its primary action as a selective KOR agonist, salvinorin-A has been shown to modify dopamine pathways, decreasing dopamine levels in rats in the caudate putamen, the dorsal striatumand the nucleus accumbens, thus implicating the dopaminergic reward circuit. It may also interact indirectly with the brain's endocannabinoid system. Recreational Salvia users report that the effects of salvironin-A generally differ from those of both serotoninergic hallucinogens and dissociative anesthetics, mainly because they involve less visual distortions, are felt more intensely, and are less enjoyable. However, there is evidence that salvinorin-A and other selective KOR agonists such as enadoline can induce ego dissolution experiences. A recent qualitative analysis of the subjective reports of 30 healthy volunteers found that 37% reported experiencing alterations in their self-awareness with depersonalization-like feelings, and 17% described letting go of their sense of self after the administration of salvinorin-A; 20% also reported a loss of the sense of bodily ownership. Another recent study suggested that the subjective effects of salvinorin-A, unlike those of serotoninergic hallucinogens, involve intense somatic effects and have a strong dissociative component. At high dosage, it was found to increase scores on the OBN subscale of the APZ questionnaire while decreasing scores on the DED subscale in healthy volunteers. Although qualitative analysis of reports and quantitative analysis with the APZ questionnaire thus converge in suggesting that KOR receptor agonists like Salvia can produce ego dissolution experiences, this ability has yet to be demonstrated with a direct validated measure of DIED, such as the new EDI. Incidentally, depersonalization disorder might be related to a dysregulation in the opioid system leading to a suppressive effect on stress response, a hypothesis seemingly confirmed by multiple successful trials on depersonalized patients with the opioid antagonist naloxone. Given the lack of brain imagining studies with selective KOR agonists, there is limited knowledge of their effects on regional activity in the brain, let alone how their action on KORs can lead to the subjective occurrence of DIED. KORs are expressed with high density in the striatum, hippocampal dentate gyrus, deep cortical layers V and VI (with more expression in the prefrontal than in the occipital cortex and most densely in the claustrum. Accordingly, it has been suggested that the subjective effects of Salvia may be due to over-activation of the KOR population in the claustrum, and in particular that the alterations of bodily self-consciousness induced by salvinorin-A might result from the indirect effect of claustrum activation on parietal cortical areas. Further investigations using brain imaging are required to gain a better understanding into the mode of action of selective KOR agonists.
If DIED is a genuine phenomenon associated with specific neurophysiological mechanisms, what can we expect to learn from its experimental study? It has been argued that if DIED consists in a breakdown of the sense of self, then any neurophysiological change associated with subjective reports of DIED following the administration of psychoactive substances might reveal which functional brain configuration is essential to the maintenance of a sense of self in the baseline state. Both the methodological and conceptual components of this program are worth discussing.
The meaning of the correlation between the occurrence of DIED and certain brain states is not entirely unproblematic. There has been considerable debate about methodological issues surrounding the search for the ''neural correlates of consciousness'' (NCCs) in general. According to an influential definition, an NCC is a minimal neural system N such that there is a mapping from states of N to states of consciousness, where a given state of N is sufficient, under certain enabling conditions, for the corresponding state of consciousness. These enabling conditions refer to the range of cases in which the neural correlation holds, which may typically include normal brain functioning, unusual inputs and brain stimulation (e.g., transcranial magnetic stimulation), but not important structural or architectural differences, due for instance to brain lesions-which might change the neural correlates of a given conscious state. By analogy, the search for ''the neural correlates of the [sense of] self''should be looking for a minimal neural system such that a given state of this system is sufficient, under the relevant enabling conditions, for having a sense of self. However, this is not what the available neurophysiological data on DIED provides. First of all, brain states of subjects undergoing DIED seem to correlate with the absence of a sense of self. Thus, the fact that the brain states of DIED subjects show functional differences from those of non-DIED subjects in the same experimental setting (i.e., following the administration of the same dosage of the same psychoactive drug) appears to indicate that these functional differences, or a certain subset of them, account for the loss of the sense of self. In turn, this can be interpreted as evidence that at least some of the neural properties of non-DIED subjects which are changed in DIED cases constitute a necessary condition for the maintenance of a sense of self, at least in normal human brains. However, it is unwarranted to infer from such experimental results that these neural properties are sufficient for the maintenance of a sense of self: they might just be neural prerequisites, that is part of the enabling conditions. Furthermore, it is impossible to know which of the functional differences between DIED and non-DIED subjects, if any, directly underlie the loss of the sense of self-that is which of them, if any, is minimally sufficient for having a sense of self. For instance, the putative roles of DMN disintegration, oscillatory rhythms in the PCC, salience network integrity and communication between the parahippocampus and the neocortex require further investigation to determine if and how they are linked to the sense of self. In addition, the broad link found in psilocybin and LSD studies between DIED and increased global cortical connectivity/increased entropy does not seem specific enough to warrant any particular claim about the neural correlate of the sense of self. In this regard, the use of psychometrically validated tools to measure DIED, such as the EDI, might contribute to establish firmer conclusions in the future. In any case, brain imaging studies of DIED can have a more indirect role, by assessing previous hypotheses about the neural correlates of the sense of self, just as imaging of non-conscious processing can cast doubt on hypotheses regarding the neural underpinning of consciousness. As) put it in a recent article, ''if a cognitive computation or neural marker, proposed by some theory to be uniquely associated with conscious processing, can be observed under demonstrably non-conscious conditions, then that theory is severely undermined''. In other words, the search for neural correlates of ego dissolution might indirectly delineate the boundaries of credible hypotheses regarding the neural prerequisites of the sense of self, just as the study of the neural correlates of unconsciousness plays a pivotal role in establishing the neurobiological conditions for consciousness.
In the expression ''neural correlates of the (sense of) self'', the word ''self'' is no less ambiguous than ''correlates''. Indeed, the concept of self is extremely polysemous and wide-ranging, and there is no consensus on its meaning in cognitive neuroscience. Attempts to clarify this ambiguity have led to the theorizing of many different notions of the self across a large number of disciplines, including: [T]he cognitive self, the conceptual self, the contextualized self, the core self, the dialogic self, the ecological self, the embodied self, the emergent self, the empirical self, the existential self, the extended self, the fictional self, the full-grown self, the interpersonal self, the material self, the narrative self, the philosophical self, the physical self, the private self, the representational self, the rock bottom essential self, the semiotic self, the social self, the transparent self, and the verbal self. This lexical proliferation only seems to further obscure the meaning of the search for ''neural correlates of the self'', as well as the interpretation of a questionnaire item such as ''I experienced a disintegration of my ''self'' or ego''. It is necessary to determine what definition of the ''self'' or ''ego'' is at play in DIED to assess the significance of the phenomenon. Most studies referring to ego dissolution experiences following drug intake describe it as a disruption of the ''sense of self'', although there is little agreement on how to understand this notion. Most of the time, it is taken for granted that waking consciousness always involves a sense of self (e.g., ''in healthy waking consciousness, one's sense of self is never far from consciousness'', Carhart-Harris et al., 2014, p. 12), which has been described as ''a complex sensory experience of being ''me'', as being coherent in mental acts and distinct from the outside world''. However, the very notion of a sense of self with a distinctive phenomenology is controversial, and the definition of the kind of ''self'' which is disrupted in DIED experiences is by no means a trivial matter. Within cognitive neuroscience, there has been a debate in recent years over the interpretation of a host of experimental results, especially regarding the activity of cortical midline structures, purported to give us insight into the neurobiological basis of the ''self'' (e.g.,. In an attempt to clarify this discussion,have introduced a distinction between self-related and self-specifying processes: while self-related processes underlie tasks in which subjects process information about themselves (such as recognizing themselves or assessing their own personality, physical appearance, attitude or feelings), self-specifying processes implement an implicit self/nonself distinction in perception, action and emotion through sensorimotor feedback loops. They argue that the study of brain processes involved in self-related tasks, such as activity in the mPFC, does not tell us anything important about the neural correlates of the self, since these processes are also involved in inferential processing and memory recall in general (including other-related tasks). By contrast, they suggest that self-specifying processes properly characterize the ''subjective perspective'', underpinned by sensorimotor processes relating any represented object to the representing subject. Drawing on a similar idea, a recent article argues that we ought to distinguish between ''being a self'', i.e., being a subject of conscious experience with a first-person perspective on the world, and ''beingself-aware'', i.e., being able to think about oneself as a subject of experience. The author suggests that experimental studies on the self-relatedness of brain processes involving cortical midline nodes focus on reflective self-awareness, whereas psychopathological self-disorders such as those observed in schizophrenia might be more related to the basic aspects of being a self. Both articles agree that the self is not entirely reducible to reflective processes in which one represents oneself, because the condition for this self-representational ability is a more fundamental form of selfhood implemented in sensorimotor processes. In the rich phenomenological tradition, running from the seminal works of Brentano and Husserl at the turn of the 20th century to contemporary philosophy, somewhat similar notions of phenomenal selfhood have been developed. In some of his works, Husserl argued that consciousness always involves a ''self-manifestation'' (Für-sich-selbst-erscheinens), defined as the subjective way in which conscious experience is given.later introduced the notion of ''pre-reflective'' self-awareness in Being and Nothingness: this minimal kind of self-awareness does not rely on an explicit subject/object distinction; rather, it is ''constitutive'' of phenomenal consciousness, and is indeed a necessary condition for it. Some contemporary philosophers defend a modern account of pre-reflective self-awareness reminiscent of the Sartrean notion, conceived as the on-going, implicit, first-order awareness of one's experience as one's own. They argue that conscious experience has a distinctive first-personal character, which comes from the fact that it is experienced as mine. This aspect of conscious states has also been called ''mineness'' and ''for-me-ness'' in recent years. According to Legrand and other authors working at the crossroad between phenomenology and cognitive science, this first-personal aspect of experience or pre-reflective self-awareness is what self-specifying processes implement at the subpersonal level. It is worth remarking that some phenomenologists who are reluctant to ''naturalize'' their project are not committed to the assumption that pre-reflective self-awareness can be explained in terms of bodily processes (on this debate see. Are those conceptual distinctions illuminating to make sense of DIED experiences? Interestinglyproposed to interpret their findings regarding the neuropharmacological mechanisms of DIED by dwelling on another distinction, between the ''narrative self'' and the ''minimal'' or ''embodied self''. They suggested that the activity of the DMN might be related to the narrative self, while functional brain processes which are affected by DIED might be more specifically related to the minimal/embodied self. The narrative self can be defined as the open-ended construction of one's own personal identity shaped by social and cultural factors, and is associated with high-level cognitive functions such as self-related attitudes, beliefs and autobiographic memory retrieval. The minimal/embodied self (also called ''minimal phenomenal selfhood'') refers instead to the basic experience of being a self rooted in bodily sensorimotor processes. Although different authors coming from distinct disciplines and traditions might specify all these distinctions in a slightly different fashion, they appear to be roughly converging towards a general dichotomy between: (a) a basic notion of the self as the first-personal aspect of normal conscious experience implemented by low-level bodily processes; and (b) a more sophisticated conception of the self as constituted by high-level reflective processes involving introspection, self-evaluation and autobiographic memory retrieval. At this stage, it is still an open question whether DIED should be interpreted as a mere disruption of the ''narrative self'' involving high-level processes linked to personal identity, or as a disruption of the ''minimal self'' rooted in bodily and sensorimotor processes. Given that self-report of DIED seems typically associated to descriptions of perceptual abnormalities, loss of bodily awareness and disturbance of self-location in space and time, it is tempting to speculate that it is linked to the disruption of low-level perceptual and bodily processes, such as the multisensory integration of self-related stimuli across visual, somatosensory, interoceptive and vestibular domains. However, DIED is a multifaceted experience, and may plausibly disrupt both narrative and embodied aspects of selfhood (see. Multisensory integration refers to the way in which the processing of stimuli from one sensory modality is sensitive to the information provided by stimuli from another. Information coming from several modalities can thus be integrated to improve perception and solve crossmodal conflicts. The multisensory integration of body-related stimuli has been recently investigated with bodily illusions induced by experimental protocols, such as the rubber hand illusionand full-body illusions using head-mounted displays. Along with autoscopic phenomena of neurological origin (including OBEs), full-body illusions induced in experimental settings have been able to dissociate three self-referential components of ordinary conscious experience, namely self-identification with a body (''what is my body?''), self-location in space (''where am I?'') and the experienced origin of the visuospatial perspective (''from where do I experience the world?''). There is good evidence that these components rely on the multisensory integration of spatiotemporally congruent exteroceptive (mainly visual), somatosensory (tactile and proprioceptive), interoceptive and vestibular signals. Multisensory body-related stimuli normally occur within a limited distance from the body, which defines the peripersonal space (PPS). The trunk-centered PPS can be reshaped and extended further away from the body in full-body illusions, which modulates self-identification to a virtual avatar and self-location outside of one's body. While body ownership is an integral part of ordinary experience, the idea that self-identification to a physical or hallucinated body is necessary for minimal selfhood has been challenged by experiences in which subjects lack the experience of having a body, such as asomatic OBEs and bodiless dreams, which are not typically described as experiences of self-loss. Accordingly, it has been suggested that the simplest form of phenomenal selfhood only requires the experience of spatiotemporal self-location; see also, which crucially rely on the multisensory integration of visuo-somatosensory and vestibular signals. It has been recently proposed that the weakening of self/world boundaries in psychosis might be linked to a disruption of self-location and PPS representation. Interestingly, phenomenological and neurophysiological evidence regarding DIED seems compatible with a similar hypothesis. Indeed, the experience of unity and the loss of boundaries commonly associated with DIED might be linked to a thorough disruption of the mechanisms underlying normal self-location. Moreover, it has recently been hypothesized that the destabilizing action of serotonergic psychedelics on layer V projections to the thalamus via GABAergic neuronal circuits from sensory areas leads to a disruption of the low-level, spontaneous integration of spatiotemporally congruent multisensory stimuli. This hypothesis would explain why psychedelic drug intake can lead to both aberrant binding of incongruent exteroceptive stimuli (resulting in synesthesia) and, at high doses, to the breakdown of the integration of congruent visuotactile and vestibular signals underlying self-location (resulting in unitive experiences and DIED). Additionally, recent fMRI studies with full-body illusions suggest that activity in the PCC plays a key role in encoding self-location, alongside multisensory processing in the TPJ. Ego dissolution induced by psilocybin and LSD has been associated with decreased oscillatory rhythms in the PCC, and NMDA antagonists have been found to decrease activity in the PCC, while ego dissolution induced by LSD was found to correlate with an increase in TPJ connectivity. This might be an additional evidence that DIED is caused by aberrant multisensory integration of self-related inputs, resulting in a loss of self-location and self/world boundaries. Although more research is needed to assess this proposal, the available data is consistent with the idea that the ''sense of self'' lost during DIED is not (or not merely) the narrative self, but the minimal self-awareness of ordinary experience rooted in sensorimotor processes. The next section will further examine this hypothesis in light of recent computational models of the minimal/embodied self, with a particular focus on Bayesian models and top-down modulation of multisensory integration.
There is converging evidence that multisensory and motor processing underlies a representation of the self which is continuously updated on the basis of incoming information. Drawing on the distinction between self-related and self-specifying processes,have argued that the self/non-self distinction which implicitly specifies the self as an embodied subject and agent is implemented by subpersonal feedback loops, such as those involved in sensorimotor integration and homeostatic regulation. They suggest that the organism continuously distinguishes between ''reafference'' (afferent signals arising as a result of the organism's own efferent processes) and ''exafference'' (afferent signals arising as a result of environmental events), and that the processes underlying this distinction are self-specifying because they implement a unique egocentric perspective in perception and action, which defines the self as the bodily subject and agent of that perspective. On this ground, they further argue that activation of the DMN is neither a necessary condition for self-experience, because activation of the TPN (with a parallel deactivation of the DMN) is not at all incompatible with the experience of being an embodied agent, nor a sufficient condition for self-experience, since regions outside the DMN (such as the lateral PFC and the insula) also seem to play a role in merely self-related processing. In other words, they hold that attention-demanding tasks do not suppress the experience of being an embodied subject and agent underpinned by self-specifying processes, and might even enhance it. This is consistent with the idea that the DMN might underlie narrative rather than embodied aspects of selfhood. This account of reafference/exafference integration as self-specifying processing fits well within a Bayesian model of the minimal/embodied self. According to the Bayesian brain theory, the brain is a hypothesis testing machine modeling the (hidden) worldly causes of sensory stimuli in a way that approximates Bayesian inference in the long term. Although many statistical models of bodily multisensory processing have focused on bottom-up integration of stimuli, recent research has also emphasized top-down modulation of such integration. The interaction between bottom-up signals and top-down modulation has been modeled by incorporating the free energy principle (FEP) and predictive coding. According to the FEP, any self-organizing system at equilibrium with its environment must minimize its free energy, thus resisting a natural tendency to disorder implied by the second law of thermodynamics. Applied to neural systems, the FEP means that brain states minimize improbable outcomes (surprise) by minimizing prediction errors through perception and action. This is consistent with the predictive coding framework, according to which the brain generates predictive hierarchical models of the world that are constantly updated on the basis of prediction error signals generated by unexpected sensory information. As mentioned in the previous sections, it has been recently hypothesized that psychedelic substances produce a ''disorganized'' brain state characterized by a higher neural entropy than the baseline state. In the predictive coding framework, the brain's predictions crucially depend on top-down prior expectations shaped by experience. In the psychedelic state, however, it has been speculated that the brain's generative models of the world are under-constrained, and as a result predictions might be suboptimal, which could explain some of the subjective effects of hallucinogenic drugs, such as perceptual distortions, greater cognitive flexibility, greater creativity and feelings of awe and bewilderment with ordinary sensory stimuli. Interestingly, recent theories of the minimal/embodied self converge in suggesting that a Bayesian perspective may contribute to explain how DIED experiences arise. Indeed, several authors have proposed to apply FEP and predictive coding frameworks to develop a neurocomputational model of the embodied self. In a predictive model of perception, bottom-up sensory error signals are explained away by top-down processes to minimize surprise in multimodal areas further up the hierarchy. It has been suggested that the embodied self ultimately results from the integration of congruent predictions regarding self-related and self-generated (endogenous) multisensory stimuli in high-level supramodal regions. In other words, if the brain predicts the worldly causes of incoming sensory inputs, it also has to predict the organism's own contribution to those inputs; thus an approximate Bayesian model of the world must include a model of the organism itself or self-model, since this is the most probable explanation of congruent sensorimotor stimuli. In terms of the FEP, the hypothesis is that in normal conditions, the model which has the lowest amount of free energy is one in which the subject itself is predicted to be the ''hidden cause'' of congruent somatosensory and homeostatic signals. The role of interoceptive signaling in the maintenance of the embodied self has also been emphasized and described within a predictive coding framework, and the symptoms of depersonalization disorder have been associated to abnormal interoceptive predictive coding dynamics. Thus, in normal conditions, the sense of self might result from the generation of a supramodal model of the single cause of congruent multisensory inputs which are ''most likely to be me'' across exteroceptive, somatosensory, interoceptive and vestibular domains. This hypothesis could shed light on disturbances of self-experience such as those found in psychosis, or indeed in drug-induced cases. Neurocognitive studies about psychosis converge in indicating that source monitoring deficits and aberrant salience may explain some of the positive symptoms of schizophrenia, and self-disturbances in particular. Indeed, if the mechanisms underlying reafferent/exafferent signaling are not functioning properly, this can result in a difficulty to distinguish between the origin of endogenous and exogenous stimuli. For example, if prediction error signals are abnormally encoded for self-generated stimuli, these will be experienced as unpredictable and will not be attenuated, which might eventually lead to the suppression of prediction errors in an updated model where these stimuli are not attributed to the self. A similar explanation based on predictive coding failures has been put forward to account for the emergence of full-blown delusions from abnormal sensory experiences. Likewise, the failure to suppress attention to irrelevant or familiar stimuli in the environment leads to aberrant salience of objects and association, which may be explained by compromised bottom-up and top-down processes underlying predictive perception in psychosis. In turn, aberrant salience of self-related stimuli might disturb the continuity and consistency of the embodied self, resulting in alien experiences. Similarly to what happens in psychosis, many subjective effects of hallucinogenic drugs seem to be linked to a failure to make accurate top-down predictions based on contextual information and prior expectancies, resulting in more unconstrained and unreliable perceptual processing, and thus ''diminishing confidence or ''certainty'' about perceived phenomena''. Like schizophrenia, hallucinogenic drugs might improve the accuracy of participants on a range of tasks in which standard top-down control normally causes a performance decline, as illustrated by a reduced susceptibility to the ''hollow mask illusion'' (in which healthy subjects see a concave mask as convex face) both in schizophreniaand after LSD administration (unpublished result of Torsten Passie's hollow mask study at the Hannover Medical School in Germany). Psilocybin and ayahuasca have also been shown to reduce binocular rivalry switching rate and even allow phenomenal fusion of rival images. Pharmacological models of psychosis emphasize the similar role of disrupted prediction errors signaling both in psychotic and drug-induced cases. The generation of mismatch negativity (MMN), the change in brain activity in response to the occurrence of an unexpected stimulus, is thought to be linked to normal functioning of NMDA receptors. A consistent decrease in the amplitude of MMN in response to unexpected stimuli is observed both in schizophrenia patients and in healthy participants pre-treated with ketamine. Ketamine and schizophrenia both increase the susceptibility to the rubber hand illusion, resulting in illusory body ownership. A recent article has linked the alterations of self-awareness and mind-reading observed in schizophrenic patients to the idea of unstable hierarchical ''self-models'' in a predictive coding framework, resulting in disrupted self-representation. In light of computational models of the minimal/embodied self, it can be hypothesized that ego dissolution is linked to a disruption of top-down and bottom-up processes modulating the multisensory integration of self-related stimuli (across interoceptive, vestibular and visuotactile domains) that normally implement self-location and a self/world boundary. Future research in this area could evaluate whether or not susceptibility to DIED after administration of psychoactive drugs is enhanced by sensory deprivation (which minimizes somatosensory reafferent signals), how psychoactive drugs can affect the experience of full-body illusions using virtual reality (in which self-location is disassociated from self-identification to a body), and if drug intake alters the boundaries of the trunk-centered PPS.
While the phenomenon of DIED has not gone unnoticed in neuropharmacological and psychiatric research, it has not yet piqued the interest of philosophers, despite its potential relevance to philosophical debates about selfhood (although see. Although there is a growing trend in empirically-oriented philosophy of mind to draw upon pathological cases in order to cast doubt on general theoretical claims about perception and cognition (e.g.,, non-pathological cases of altered conscious states such as those induced by psychoactive drugs are rarely mentioned. However, there are at least two ways in which the study of DIED could benefit a subset of philosophical debates regarding the self.
The phenomenology of DIED appears to put pressure on the claim that one is self-aware whenever one is conscious. Following the influential formulation of, a mental state is often said to be phenomenally conscious if and only if there is something it is like for a subject to be in that state. The qualitative character of a phenomenally conscious state refers to the experiential qualities or qualia of that state: when I have a visual experience of a red apple, ''reddishness'' is part of the qualitative character of this phenomenally conscious experience. In recent years, several authors have argued that the qualitative character of experience does not exhaust phenomenal consciousness. These authors hold that another aspect of conscious experience exists alongside qualia, namely its subjective character. The subjective character of a conscious state refers to the fact that there is something it is like for me to be in a given state. As some of the advocates of this distinction put it, the subjective character does not capture the what-it-islike-ness of the conscious state, but its for-me-ness: while my experiences of seeing a red apple and seeing a green apple differ in their qualitative character, they are said to be the same with respect to their subjective character, because in both cases it is for me that it is like something to have them. According to a bundle of theories which have been collectively referred to as ''subjectivity theories of consciousness'', subjective character is a necessary condition of phenomenal consciousness, because the two are constitutively linked. These theories endorse the following ''subjective character principle'' (SCP): (SCP) Necessarily, a mental state is phenomenally conscious if and only if it has subjective character. However, the notion of subjective character is ambiguous (see): while it is sometimes defined as an ''inner'' or ''peripheral'' awareness of one's own experience, it has also been equated with a kind of self-awareness (e.g.,. Therefore, it is not clear that so-called subjectivity theories all endorse the claim that self-awareness properly speaking (an awareness of oneself, or a sense of self) is a necessary condition for consciousness. In any case, even outside of the debate about SCP, many publications in neuroscience, psychology and philosophy have endorsed the general idea that consciousness necessarily involves some kind of sense of self or self-awareness (e.g.,. Let us call this specific claim the ''self-awareness principle'' (SAP) 5 : (SAP) Necessarily, whenever one is in a conscious state, one is minimally self-aware. This is a theoretical claim, but one that ultimately bears on empirical matters: if it were shown that there are in fact instances in which a subject is in a phenomenally conscious state without being self-aware in any way, then SAP would be prima facie invalidated on empirical grounds. For instance, Kriegel admits that he ''cannot envisage what it would be like to have a phenomenology lacking the kind of inner awareness that constitutes for-me-ness.''6 . However, a number of pathological cases have been brought up as potential threats to such a claim.have discussed some of these anomalous experiences under the label ''alienation symptoms'', including thought insertion, delusions of alien control, somatoparaphrenia and loss of bodily ownership. According to them, alienation symptoms can be explained within subjectivity theories, if they arise when a first order non-conscious alien mental state occurs in simultaneity with a second order non-alien conscious state that represents the first order state. It has been argued that this explanation is inconsistent with empirical data about the neural correlates of alienation experiences, but regardless of this issue it is not clear that it can properly accommodate the phenomenon of DIED. If I have a thought that feels inserted in my mind, it still makes sense to say that I am aware of this thought, and indeed that I am aware of it as alien. However, subjective reports of ego dissolution experiences suggest that they lack this firstpersonal aspect altogether. In narrative self-reports, drug users are often reluctant to use the first person pronoun at all when describing DIED. For instance, one narrative report describing a DIED experience after intake of Psilocybe mushrooms includes the following comment: ''There existed no one, not even me . . . so would it be proper to still speak of ''I'', even as the notion of ''I'' seemed so palpably illusory?'' 7 . Nevertheless, self-reports clearly converge in indicating that DIED is a conscious experience, and one that is memorable. 5 Most proponents of SCP seem to accept SAP (e.g.,, and some even claim that the latter is entailed by the former (see). 6 Although Kriegel seems to define for-me-ness as ''peripheral inner awareness'' of one's concurrent experience here, he defines it elsewhere as ''a minimum point of self-consciousness''. He comes close to explicitly endorsing SAP, although he does not formulate a necessity claim: ''my current experience's pre-reflective self-consciousness strikes me as egological-that is, as a form of peripheral self -awareness. . . There is an elusive sense of self-presence or self-manifestation inherent in even a simple conscious experience of the blue sky.''. See also): ''If 'self-consciousness' is taken to mean 'consciousness with a sense of self', then all human consciousness is necessarily covered by the term-there is just no other kind of consciousness as far as I can see''; and: ''self-awareness is an integral function of all conscious experiences''. 7 The Phenomenology of Minimal Selfhood The proper assessment of SAP crucially depends on whether there is indeed a kind of minimal self-awareness or sense of self surfacing at the personal level in conscious experience, rather than merely subpersonal self-specifying processes with no counterpart at the conscious level. If so, it is presumably not a salient feature of experience, but rather something like a structural ''invariant'' that goes unnoticed most of the time 8 . But even on such a reading, DIED experiences seem to threaten SAP. While the sense of self might be in the background of normal waking consciousness in such a way that we don't usually pay attention to (or focus on) this aspect of experience, ego dissolution phenomena suggest that such background awareness can suddenly become prominent when it is deeply altered-somewhat as the interruption of background music suddenly brings to one's focal attention the fact that it was discreetly playing before. Thus, DIED experiences present an interest for philosophers as a potential challenge to the idea that there is no phenomenology of the self. Even if it is true, as Hume famously wrote in his Treatise of Human Nature, that the ''self'' is nowhere to be found when I survey the contents of my conscious experience, the fact that DIED is described as a breakdown of the alleged subjective structure of experience may indicate that such structure is otherwise part of one's conscious experience. Reminiscent of how endogenous stimuli such as self-produced tactile stimulation are attenuated in normal conditions, minimal phenomenal selfhood need not be a salient feature of one's conscious states. According to the hypothesis presented in this article, it might be implicit in conscious experience when multisensory endogenous stimuli are correctly integrated at the subpersonal level, and might only come to the fore when these self-specifying processes start dysfunctioning. Therefore, philosophers interested in self-awareness and minimal/embodied selfhood might draw on descriptions of DIED experiences to discuss the extent to which a minimal sense of self is indeed part of one's conscious experience in normal situations. There is room, however, for at least two different interpretations of DIED which do not threaten SAP. The first alternative interpretation, mentioned in the section ''The Broad Dichotomy between Two Concepts of Self'', takes DIED to be a mere disruption of high-level processes underlying the ''narrative self'' (such as one's network of self-related beliefs and autobiographical memory). On this construal, DIED might impair ''reflective'' or ''conceptual'' self-consciousness (one's ability to think about oneself and self-ascribe conscious experiences) without undermining the subjective character of consciousness. According to a second alternative interpretation, DIED does not subtract something that was supposedly present before in the experience, but rather adds something to the ordinary structure of consciousness, such as a feeling of alienation. As mentioned in the section ''Phenomenal Consciousness and Self-Awareness'', this ''something extra'' strategy has been invoked by proponents of subjectivity theories to deny that thought insertion and passivity experiences could threaten their claim. It is worth noting that a similar strategy can also be used by opponents of SAP; indeed, it may be that the subpersonal processes disrupted by DIED do not normally underlie any kind of self-awareness, while their disruption does produce the feeling of losing one's sense of self. If this was the case, then self-specifying processes such as multisensory processing of self-related stimuli would not normally correlate with any kind of ''sense of self'', but their disturbance would correlate with the experience of ego dissolution. Although this interpretation is not excluded by available evidence, it does not sit very well with the hypothesis that the processes undermined during DIED are linked to bodily awareness and the experience of spatiotemporal selflocation, since there is some empirical evidence that the latter does pervade ordinary conscious experience. According to another alternative interpretation, it may be the case that DIED alters self-awareness through a dissociation of automatic processing from the self, resulting in the experience of perception, thought and movement as alien. Such a hypothesis is rooted in the ''perceptual anomalies'' approach to schizophrenic self-disturbances in schizophrenia, inspired by Beringer's and Mayer-Gross' early experiments with mescaline.
This article reviewed current knowledge about the phenomenon known as DIED. While there is good evidence from both anecdotal narrative reports and quantitative data that the experience of losing one's sense of self can occur in healthy subjects following the intake of certain psychoactive drugs at high doses, its neurophysiological etiology is not yet fully understood. This experience seems to occur with three neuropharmacological classes of substances: classical psychedelics which act as selective agonists of the serotonin 2A receptor subtype, dissociative anesthetics which act as antagonists of the glutamate NDMA receptor subtype, and selective KOR agonists. Whether or not the neurocognitive mechanisms which bring about DIED experiences are broadly similar with these three classes of substances, despite their primary action on different neurotransmitter receptors, remains an open question. The occurrence of DIED after psychedelic intake (psilocybin and LSD) appears to correlate with DMN disintegration, increased global functional connectivity and increased neural entropy, but further research is required to establish more fine-grained correlations and compare the results with other classes of psychoactive drugs. The dependence of DIED experiences on doses could also be better understood. In addition, more research is needed to assess the phenomenological unity of DIED across compounds. One promising avenue of investigation is the use of specific validated questionnaires such as the EDI for a systematic assessment of the extent to which each psychoactive compound can produce ego dissolution. There is now good evidence in the case of classical psychedelics that DIED is a valid and unidimensional construct which can be reliably measured. However, there are also well-documented differences between the subjective effects of classical psychedelics, dissociative anesthetics and KOR agonists (e.g., geometrical patterns with psilocybin and LSD, experiences of disembodiment with ketamine, or interoceptive and somatosensory illusions with Salvia). It is intriguing to speculate that ego dissolution does not share the exact same experiential characteristics across these different classes of compounds, although more evidence is required. More generally, one may wonder to what extent experiences of ego dissolution induced by drugs, psychosis and deep meditation share a common core phenomenology. DIED is often described as the loss of one's ''sense of self'', and narrative reports converge in suggesting that it is indeed experienced as the breakdown of the basic subjective character of conscious experience. Recent neurocomputational models of the ''minimal'' or ''embodied'' self, which refers to the experience of being a subject in perception and action, suggest that it might be related to multisensory processing of self-related stimuli, and explained within Bayesian models. In such models, minimal phenomenal selfhood relies on the proper integration of congruent visual, somatosensory, interoceptive and vestibular feedback about one's body, location and orientation in higher cortical areas, which specifies a minimal sense of self as the result of hierarchical predictions minimizing surprise (i.e., explaining away prediction errors). Psychoactive drugs able to induce ego dissolution have been hypothesized to disrupt the weighting of top-down predictions and bottom-up prediction errors in perception, including multisensory processing. Therefore, such computational models of phenomenal selfhood are consistent with the occurrence of DIED experiences, and might even be good candidates to explain them. Moreover, similar computational mechanisms have been hypothesized to underpin disturbances of self-experience in acute psychosis. This theoretical convergence informs the hypothesis that DIED is linked to abnormal processing of multisensory endogenous stimuli, leading to the loss of self/world boundary and self-location, and eventually feelings of non-existence. DIED experiences are also relevant to philosophical discussions about the subjective character of experience, insofar as they challenge the claim that minimal self-awareness is necessary for consciousness. On the other hand, they also seem consistent with the idea that ordinary conscious experience involves a minimal kind of self-awareness, characterized by self-referential aspects such as body ownership, self-location and the egocentric structure of the visuospatial perspective. This might explain why the occurrence of DIED, in which these aspects appear to be missing (or at least thoroughly altered), is perceived as such a dramatic change in the structure of conscious experience. Given the relevance of DIED to a number of theoretical issues in both cognitive science and philosophy, it is important to gain a better understanding of its phenomenology, beyond the limited level of detail usually found in psychometric questionnaires and online narrative self-reports. Future research could greatly benefit from fined-grained descriptions of the experience from onset to end, using proven methods to avoid theoretical and cognitive biases. For instance, the micro-phenomenological technique developed by Vermersch and Petitmengin was devised to elicit a disciplined description of the past lived experience associated with a given cognitive process, including subtle aspects unnoticed by the subject at first. This method has proven particularly efficient for eliciting very detailed descriptions of ''the micro-dynamics of experience'' at the level of brief mental events. It has been independently applied to anomalous bodily experiences such as the rubber hand illusionand the loss of self/world boundaries in expert mindfulness meditation. The use of similar techniques with DIED subjects in a controlled setting could overcome the issue of the seemingly ''ineffable'' character of the experience, and bring to light fine-grained aspects of the phenomenon which have not yet been well documented. First-person methods could also be incorporated within neurocognitive studies, in the spirit of ''neurophenomenology'', to further bridge the gap between subjective accounts and brain imaging of DIED, and find more detailed neural correlations. Ego dissolution experiences are so remote from normal waking consciousness that it is important for researchers to rely on detailed and reliable subjective descriptions that can be crossvalidated. The complementary use of both quantitative methods (such as the new EDI) and qualitative methods (such as the microphenomenological interview) could go a long way towards establishing a science of DIED.
Create a free account to open full-text PDFs.
Carhart-Harris, R. L., Leech, R., Erritzoe, D. et al. · Schizophrenia Bulletin (2012)
Carhart-Harris, R. L., Leech, R., Shanahan, M. et al. · Frontiers in Human Neuroscience (2014)
Carhart-Harris, R. L., Muthukumaraswamy, S., Roseman, L. et al. · PNAS (2016)
Carter, O. L., Hasler, F. ;., Pettigrew, J. D. et al. · Psychopharmacology (2007)
Cohen, S. · Journal of Nervous and Mental Disease (1980)
Cummins, C., Lyke, J. · Journal of Psychoactive Drugs (2013)
William Deakin, J. F., Lees, J., McKie, S. et al. · JAMA Psychiatry (2008)
Gouzoulis-Mayfrank, E., Heekeren, K., Neukirch, A. et al. · Pharmacopsychiatry (2005)
Griffiths, R. R., Johnson, M. W., Richards, W. A. et al. · Psychopharmacology (2011)
Griffiths, R. R., Richards, W. A., Mccann, U. et al. · Journal of Psychopharmacology (2006)
Halberstadt, A. L. · Behavioural Brain Research (2014)
Hasler, F., Grimberg, U., Benz, M. A. et al. · Psychopharmacology (2004)
Johnson, M. W., Maclean, K. A., Reissig, C. J. et al. · Drug and Alcohol Dependence (2011)
Lebedev, A. V., Kaelen, M., L€ Ovd En, M. et al. · Human Brain Mapping (2016)
Lebedev, A. V., L€ Ovd En, M., Rosenthal, G. et al. · Human Brain Mapping (2015)
Letheby, C., Gerrans, P. · Neuroscience of Consciousness (2017)
Maqueda, A. E., Valle, M., Addy, P. H. et al. · International Journal of Neuropsychopharmacology (2015)
Muthukumaraswamy, S. D., Carhart-Harris, R. L., Moran, R. J. et al. · Journal of Neuroscience (2013)
Nichols, D. E. · Pharmacology and Therapeutics (2004)
Nour, M. R., Carhart-Harris, R. L. · British Journal of Psychiatry (2017)
Nour, M. R., Evans, J., Nutt, D. J. et al. · Frontiers in Human Neuroscience (2016)
Osmond, H. · Annals of the New York Academy of Sciences (2010)
Pahnke, W. N. · Psychedelic Review (1969)
Palhano-Fontes, F., Andrade, K. C., Tófoli, L.F. et al. · PLOS ONE (2015)
Riba, J., Rodríguez-Fornells, A., Barbanoj, M. J. · Psychopharmacology (2002)
Strassman, R. J., Qualls, C. R., Uhlenhuth, E. H. et al. · JAMA Psychiatry (1994)
Studerus, E., Gamma, A., Kometer, M. et al. · PLOS ONE (2012)
Studerus, E., Gamma, A., Vollenweider, F. X. · PLOS ONE (2010)
Studerus, E., Kometer, M., Hasler, F. et al. · Journal of Psychopharmacology (2010)
Tagliazucchi, E., Roseman, L., Kaelen, M. et al. · Current Biology (2016)
Vollenweider, F. X., Kometer, M. · Nature Reviews Neuroscience (2010)
Vollenweider, F. X., Leenders, K. L., Maguire, P. et al. · Neuropsychopharmacology (1997)
Vollenweider, F. X., Vollenweider-Scherpenhuyzen, M. F. I., Bäbler, A. et al. · NeuroReport (1998)
Papers in Blossom that reference this study
Coleman, J. A., Shinozuka, K., Tromm, R. et al. · Human Brain Mapping (2025)
McAlpine, R., Kamboj, S. K. · Scientific Reports (2024)
Orłowski, P., Hobot, J., Ruban, A. et al. · Psychophysiology (2024)
Gründer, G., Brand, M., Mertens, L. J. et al. · Lancet Psychiatry (2024)
Mathai, D. S., Hilbert, S., Sepeda, N. D. et al. · Psychedelic Medicine (2023)
Harduf, A., Panishev, G., Harel, E. V. et al. · Scientific Reports (2023)
Greń, J., Tylš, F., Lasocik, M. et al. · Frontiers in Psychology (2023)
Buchborn, T., Kettner, H., Kartner, L. et al. · Frontiers in Neuroscience (2023)
Mallaroni, P., Mason, N. L., Kloft, L. et al. · Frontiers in Neuroscience (2023)
Kaup, K. K., Vasser, M., Tulver, K. et al. · Frontiers in Psychiatry (2023)
Ponomarenko, P., Seragnoli, F., Calder, A. et al. · Journal of Psychopharmacology (2023)
Brasher, T., Rosen, D., Spinella, M. · International Journal of Wellbeing (2023)
Timmermann, C., Vollenweider, F. X. · Trends in Cognitive Sciences (2023)
Madsen, M. K., Ozenne, B., Armand, S. et al. · Frontiers in Psychology (2022)
Cruzat, J., Perl, Y. S., Escrichs, A. et al. · Network Neuroscience (2022)
Kałużna, A., Schlosser, M., Gulliksen Craste, E. et al. · Journal of Psychedelic Studies (2022)
Stoliker, D., Egan, G. F., Friston, K. J. et al. · Pharmacological Reviews (2022)
Girn, M., Roseman, L., Bernhardt, B. et al. · NeuroImage (2022)
Glowacki, D. R., Wonnacott, M. D., Freire, R. et al. · Scientific Reports (2022)
Vollenweider, F. X., Smallridge, J. W. · Pharmacopsychiatry (2022)
Stoliker, D., Novelli, L., Vollenweider, F. X. et al. · MedRvix (2021)
Whitfield, H. J. · Frontiers in Psychiatry (2021)
Deane, G. · Neuroscience of Consciousness (2021)
Kočárová, C., Horacek, J., Carhart-Harris, R. L. · Frontiers in Psychiatry (2021)
Ballentine, G., Friedman, S. F., Bzdok, D. · Science Advances (2021)
Gründer, G., Jungaberle, H., Gründer, G. · Pharmacopsychiatry (2021)
Brouwer, A., Carhart-Harris, R. L. · Journal of Psychopharmacology (2020)
Schmid, Y., Gasser, P., Oehen, P. et al. · Journal of Psychopharmacology (2020)
Deane, G. · Philosophy and the Mind Sciences (2020)
Rosenbaum, D., Weissman, C. R., Anderson, T. et al. · Journal of Psychopharmacology (2020)
Wolff, M., Evens, R., Mertens, L. J. et al. · Frontiers in Psychiatry (2020)
Ho, J. T., Preller, K. H., Lenggenhager, B. · Neuroscience and Biobehavioral Reviews (2020)
Kettner, H., Gandy, S., Haijen, E. C. H. M. et al. · International Journal of Environmental Research and Public Health (2019)
Pallavicini, C., Vilas, M. G., Villarreal, M. et al. · NeuroImage (2019)
Carhart-Harris, R. L., Friston, K. J. · Pharmacological Reviews (2019)
Bayne, T., Carter, O. · Neuroscience of Consciousness (2018)
Milliere, R., Carhart-Harris, R. L., Roseman, L. et al. · Frontiers in Psychology (2018)
Timmermann, C., Roseman, L., Williams, L. et al. · Frontiers in Psychology (2018)
Carhart-Harris, R. L. · Neuropharmacology (2018)
Swanson, L. R. · Frontiers in Pharmacology (2018)
Sanz, C., Zamberlan, F., Erowid, E. et al. · Frontiers in Neuroscience (2018)
Letheby, C., Gerrans, P. · Neuroscience of Consciousness (2017)